Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Lluis Tort Bardolet

Lluis Tort Bardolet

Institutions of which they are part

Protein kinases in cancer research
Vall Hebron Institut de Recerca
Lluis Tort Bardolet

Lluis Tort Bardolet

Lluis Tort Bardolet

Institutions of which they are part

Protein kinases in cancer research
Vall Hebron Institut de Recerca

Related news

Laboratori de Sarcomes Infantils

VHIR drives cancer research with new personalized therapies and advances in biomarkers

On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.

Laboratori de Sarcomes Infantils

New therapeutic target for an aggressive childhood cancer affecting the muscles

The research team has shown that inhibiting the TRIB3 protein slows the growth of rhabdomyosarcoma and improves survival in animal models.

Dr. José Miguel Lizcano i Dr. Sergio Espinosa

Study identifies strategy to avoid resistance to cancer therapy

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

See more

Related professionals

David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more
SILVIA GARTNER TIZZANO

SILVIA GARTNER TIZZANO

Main researcher
Growth and Development
Read more
Luca Basile

Luca Basile

Administration and Management
Microbiology
Read more
Ana Leon Espitia

Ana Leon Espitia

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.